Neurodegenerative Diseases Drugs Market Set to reach USD 77.76 billion by 2030

According to the study by Next Move Strategy Consulting, the global Neurodegenerative Diseases Drugs Market size is predicted to reach USD 77.76 billion with a CAGR of 7.2% till 2030.

The major driving factor of the growth of the neurodegenerative diseases drugs market is the increasing prevalence of neurodegenerative disorders, such as dementia, spinal muscular atrophy, and Friedreich ataxia around the globe. 

The North American region holds the lion's share in the neurodegenerative disease drugs market trends, and is expected to continue to dominate the market during the forecast period. 

Request for a FREE Sample PDF : https://www.nextmsc.com/neurodegenerative-diseases-drugs-market/request-sample